Form 4: Teladoc Health Executive Stephany Verstraete Reports Stock Transactions

Stephany Verstraete, Chief Marketing Officer of Teladoc Health, reports acquisition and disposal of common stock and derivative securities, including performance stock units and restricted stock units.

Summary

• On March 5, 2024, Stephany Verstraete, Chief Marketing Officer of Teladoc Health, filed a Form 4 detailing changes in beneficial ownership.
• The report includes transactions from March 1, 2024, and March 4, 2024.
• Verstraete acquired common stock through the conversion of performance stock units and restricted stock units.
• She also disposed of 7,945 shares of common stock on March 4, 2024, at a price of $14.516 per share to cover tax withholding obligations.
• Following these transactions, Verstraete beneficially owns 56,486 shares of common stock directly.
• She also holds derivative securities, including 13,313 performance stock units and 26,042 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency into the transactions of company insiders.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership, but the sale was primarily for tax obligations.
• Employees holding similar stock units may be interested in the vesting schedules and tax implications.

Key Dates